Altria is purchasing full global ownership of privately-held NJOY to take control of the only pod-based e-vapor product with market authorizations from the U.S. Food and Drug Administration (FDA). The ...
Following a rigorous scientific evaluation, the U.S. Food and Drug Administration (FDA) has granted marketing approval to four menthol-flavored e-cigarette products through the premarket tobacco ...
The FDA recently authorized the sale of four menthol-flavored NJOY products from Altria. NJOY could help the company return to revenue growth. The stock is inexpensive with a robust dividend that is ...
TEMPO.CO, Jakarta - The U.S. Food and Drug Administration authorized four of Altria's (MO.N) menthol e-cigarette products for sale in the country on Friday, June 12, making them the first-ever ...
Altria (MO) is currently one of my largest portfolio holdings and a very popular stock amongst dividend investors. And for good reason. The stock has more than 50 years of dividend increases and looks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results